Oralject applications are very easy to administer. Oralject does not require any specialists or specific skills; a single meal is simply replaced with Oralject. This simplicity opens a new door to mass inoculation. However, the key advantage of this technology is that it is cost effective. Regular injection not only requires expensive specialists and equipment, it can also generate significant indirect costs for producers (estimated to be as high as the direct costs) as a result of livestock stress, mortalities, adhesion, necrosis and eating disorders. With no needles and a simple administration procedure, Oralject technology provides a straightforward, cost-effective solution that requires only minimal human labour, thus is ideal for rapid mass vaccination of large populations of animals.

The Oralject technology is very flexible and adaptable. Vaccines, peptides, proteins, antibodies - the Oralject delivery platform can be applied to a wide range of bioactive compounds in monogastric species. This versatility makes Oralject the ideal solution for a large variety of applications. Furthermore, all the compounds of Oralject are classified as Generally Regarded As Safe (GRAS), a key advantage that simplifies regulatory approval for new applications.

Easy to administer
The capacity to orally administer different bioactive compounds will greatly simplify market acceptance of these substances, and by extension, increase their use. Oralject™ does not require any specialists or specific skills; normal food is simply replaced with Oralject™. This simplicity opens a new door to mass inoculation, which represents a significant advantage for the control of disease outbreaks, not only for livestock production but also for human pandemics.

For decades, the human pharmaceutical industry has been seeking an efficient oral delivery technology to replace invasive injection procedures and offer a more convenient, less traumatic, delivery option. Oralject™ provides the answer.